Alethia Young

Stock Analyst at Cantor Fitzgerald

(3.77)
# 758
Out of 4,650 analysts
149
Total ratings
56.67%
Success rate
40.12%
Average return

Stocks Rated by Alethia Young

Arcus Biosciences
Jul 5, 2024
Reiterates: Overweight
Price Target: n/a
Current: $16.66
Upside: -
Arrowhead Pharmaceuticals
Jun 20, 2024
Reiterates: Overweight
Price Target: n/a
Current: $20.18
Upside: -
Regeneron Pharmaceuticals
Oct 16, 2023
Maintains: Neutral
Price Target: $800$850
Current: $928.61
Upside: -8.47%
ALX Oncology Holdings
Sep 12, 2023
Reiterates: Overweight
Price Target: $18
Current: $1.46
Upside: +1,132.88%
Curis
Sep 7, 2023
Reiterates: Overweight
Price Target: $60
Current: $4.92
Upside: +1,119.51%
Longboard Pharmaceuticals
Aug 22, 2023
Reiterates: Overweight
Price Target: $16
Current: $59.68
Upside: -73.19%
Eledon Pharmaceuticals
Aug 22, 2023
Reiterates: Overweight
Price Target: $9
Current: $3.37
Upside: +167.06%
Verastem
Jul 6, 2023
Reiterates: Overweight
Price Target: $34
Current: $3.39
Upside: +902.95%
Biogen
Oct 15, 2021
Maintains: Neutral
Price Target: $427$327
Current: $185.01
Upside: +76.75%
Adverum Biotechnologies
Jul 23, 2021
Downgrades: Neutral
Price Target: $230$30
Current: $7.92
Upside: +278.79%
Maintains: Overweight
Price Target: $51$71
Current: $1.93
Upside: +3,578.76%
Maintains: Overweight
Price Target: $285$281
Current: $476.37
Upside: -41.01%
Initiates: Overweight
Price Target: $8
Current: $1.63
Upside: +390.80%
Maintains: Overweight
Price Target: $86$98
Current: $2.87
Upside: +3,314.63%
Maintains: Overweight
Price Target: $280$295
Current: $317.17
Upside: -6.99%
Reiterates: Overweight
Price Target: $84$86
Current: $88.76
Upside: -3.11%
Maintains: Overweight
Price Target: $30$48
Current: $24.35
Upside: +97.13%
Initiates: Overweight
Price Target: $30
Current: $24.79
Upside: +21.02%
Maintains: Overweight
Price Target: $70$72
Current: $46.08
Upside: +56.25%
Assumes: Overweight
Price Target: $5
Current: $1.84
Upside: +171.74%
Maintains: Neutral
Price Target: $83$100
Current: $65.69
Upside: +52.23%
Reiterates: Overweight
Price Target: $28$24
Current: $0.37
Upside: +6,325.70%
Reiterates: Overweight
Price Target: $185$201
Current: $129.44
Upside: +55.28%
Reiterates: Overweight
Price Target: $86$85
Current: $40.48
Upside: +109.98%
Maintains: Overweight
Price Target: $30$32
Current: $7.24
Upside: +341.99%
Reiterates: Overweight
Price Target: $211$217
Current: $130.26
Upside: +66.59%
Maintains: Neutral
Price Target: $75$48
Current: $30.49
Upside: +57.43%
Downgrades: Underperform
Price Target: n/a
Current: $9.11
Upside: -
Maintains: Outperform
Price Target: $151$154
Current: $286.91
Upside: -46.32%
Maintains: Outperform
Price Target: $113$116
Current: $70.13
Upside: +65.41%
Maintains: Outperform
Price Target: $147$106
Current: $2.83
Upside: +3,645.58%
Maintains: Outperform
Price Target: $24$28
Current: $16.34
Upside: +71.36%
Maintains: Neutral
Price Target: $85$82
Current: $162.20
Upside: -49.45%
Initiates: Underperform
Price Target: n/a
Current: $349.71
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $3.00
Upside: -